SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 3, 1997
MIRAVANT MEDICAL TECHNOLOGIES
(Exact name of registrant as specified in its charter)
Delaware 0-25544 77-0222872
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
7408 Hollister Avenue
Santa Barbara, California 93117
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 805/685-9880
PDT, INC.
(Former name or former address, if changed since last report)
Page 1
<PAGE>
ITEM 5. OTHER EVENTS.
Miravant Medical Technologies, a Delaware corporation (the "Registrant"),
completed a private equity offering on October 3, 1997 totalling $25 million,
with one investor. The transaction included the issuance of 500,000 shares of
the Registrant's common stock at $50 per share which are subject to restrictions
for a period of one year. The investor also received warrants to purchase
additional shares at higher prices which are also subject to resale restrictions
for a period of one year.
This offerint was in addition to the recent $45 million private equity
offering on similiar terms concluded September 26, 1996.
The proceeds from the transaction will be used for ongoing research,
development and commercialization efforts of the Company, as well as general
corporate purposes.
ITEM 7. EXHIBITS
None
Page 2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MIRAVANT MEDICAL TECHNOLOGIES,
a Delaware corporation
(Registrant)
By: /s/ John M. Philpott
------------------------
Chief Financial Officer
Date: October 17, 1997
Page 3
